Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global blood screening market 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Technology trends
2.1.5 End-use trends
Chapter 3 Blood Screening Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of infectious diseases
3.2.1.2 Advancements in blood screening technology
3.2.1.3 Growing blood transfusion procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced technologies
3.2.2.2 Limited access to trained professionals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By end-use
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technological landscape
3.7 Pricing analysis
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Company market share analysis, 2023
4.4 Competitive analysis of major market players, 2023
4.5 Competitive positioning matrix, 2023
4.6 Strategy dashboard, 2023
Chapter 5 Blood Screening Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Reagents & kits
5.2.1 NAT reagents & kits
5.2.1.1 Enzymes & polymerases
5.2.1.2 Standards & controls
5.2.1.3 Probes & primers
5.2.1.4 Buffer, nucleotides, and solutions
5.2.1.5 Labelling & detection reagents
5.2.2 ELISA
5.2.2.1 Immunosorbents
5.2.2.2 Controls
5.2.2.3 Conjugates
5.2.2.4 Substrates
5.2.2.5 Sample diluents & wash solutions
5.2.3 Other reagents & kits
5.3 Instruments
Chapter 6 Blood Screening Market Size and Forecast, By Technology, 2018-2032 (USD Million)
6.1 Key trends, by technology
6.2 Nucleic acid test
6.2.1 Transcription-mediated amplification
6.2.2 Real-time PCR
6.3 Serology/immunoassays
6.3.1 Chemiluminescence immunoassay
6.3.2 Fluoresecent immunoassays
6.3.3 Colorimeter immunoassays/ELISA
6.4 Rapid test
6.5 Western blot assays
6.6 Next generation sequencing
Chapter 7 Blood Screening Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Blood banks
7.4 Pathology laboratories
Chapter 8 Blood Screening Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 F. Hoffmann-La Roche Ltd.
9.3 Grifols, S.A.
9.4 Hologic, Inc.
9.5 QIAGEN N.V.
9.6 Becton, Dickinson and Company
9.7 Bio-Rad Laboratories, Inc.
9.8 Siemens Healthineers AG
9.9 Thermo Fisher Scientific, Inc.
9.10 SOFINA s.a (Biomerieux)
9.11 Danaher Corporation
9.12 Ortho-Clinical Diagnostics, Inc.
9.13 DiaSorin S.p.A.
